NVSA - New Vista Acquisition Profile, Share Price, Market Analysis, Charts, Fundamentals

Company Name, Ticker, Suppliers, else..

Severe hit for Navidea Biopharmaceuticals Inc in the fiscal time-frame ending December 31 2022

For the most recent fiscal period Navidea Biopharmaceuticals Inc decreased a loss per share of $-0.11 per share compare to $-0.12 a year ago and EPS improved from $-0.25 per share from the preceding financial reporting period.

Sales dropped sharply to $0.00 millions from $0.05 millions in the comparable financial reporting period a year ago and sequentially from $0.01 millions.

Compelling period by Cvd Equipment Corporation amid the October to December 31 2022 span

For the October to December 31 2022 period Cvd Equipment Corporation bottom-line turned positive of $0.23 per share compare to $-0.18 a year ago and EPS elevated on the another level by 2186.94 % from $0.01 per share from the previous reporting period.

Sales rose strongly by 53.274 % to $7.23 millions from $4.72 millions in the corresponding reporting period a year ago and sequentially Sales deteriorated by -10.945 % from $8.12 millions.

Existing costs were growing at the company in the most recent fiscal period

As the earnings cycle of fiscal October to December 31 2022 season resumes, countless businesses have reported the respective earnings. In the thick of it, have been several companies in the Blank Checks industry. And now, Mdwerks Inc announced operating shortfall of $-0.078423 millions, for the most recent fiscal period.

Vanishing Diminishing Returns at the Interpace Biosciences Inc in the fourth quarter of 2022

For the fourth quarter of 2022 PDII decreased a loss per share of $-0.36 per share compare to $-0.89 a year ago and earnings per share improved from $-3.35 per share from the preceding reporting period.

Sales went down sharply by -63.875 % to $3.92 millions from $10.85 millions in the comparable reporting period a year ago and sequentially Sales Tumbled by -52.119 % from $8.19 millions.

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071

NVSA Company Profile

Severe hit for Navidea Biopharmaceuticals Inc in the fiscal time-frame ending December 31 2022

Compelling period by Cvd Equipment Corporation amid the October to December 31 2022 span

Intellinetics Inc disclosed important Top-line progress, all along the financial time-frame ending December 31 2022

Existing costs were growing at the company in the most recent fiscal period

Vanishing Diminishing Returns at the Interpace Biosciences Inc in the fourth quarter of 2022


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar SGC's Profile Stock Price SGC's Financials Business Description Fundamentals Charts & Quotes SGC's News Suppliers SGC's Competitors Customers & Markets Economic Indicators SGC's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness